{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:29:47Z","timestamp":1790627387874,"version":"4.1.0"},"reference-count":238,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.medmal.2017.01.007","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T04:32:59Z","timestamp":1488861179000},"page":"92-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Proposal for shorter antibiotic therapies"],"prefix":"10.1016","volume":"47","author":[{"given":"C.","family":"Wintenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Guery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Castan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Diamantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lesprit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"P\u00e9an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Peju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Piroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Strady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vuotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gauzit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2017.01.007_bib1000","series-title":"Rapport du groupe de travail sp\u00e9cial pour la pr\u00e9servation des antibiotiques [rapport_antibiotiques.pdf] [Internet]","year":"2016"},{"key":"10.1016\/j.medmal.2017.01.007_bib1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/759138","article-title":"Review article duration of antimicrobial therapy in community acquired pneumonia: less is more","author":"Pinzone","year":"2014","journal-title":"Sci World J"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib1010","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1093\/cid\/cis370","article-title":"IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults","volume":"54","author":"Chow","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00006454-200005000-00015","article-title":"Duration of therapy for acute otitis media","volume":"19","author":"Hoberman","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"21","key":"10.1016\/j.medmal.2017.01.007_bib1020","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.279.21.1736","article-title":"Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis","volume":"279","author":"Kozyrskyj","year":"1998","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib1025","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/00006454-199707000-00011","article-title":"Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis","volume":"16","author":"Pichichero","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1067\/mhn.2001.114311","article-title":"A prospective observational study of 5-, 7-, and 10-day antibiotic treatment for acute otitis media","volume":"124","author":"Pichichero","year":"2001","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.medmal.2017.01.007_bib1035","unstructured":"2011-infections-respir-hautes-recommandations.pdf [Internet]. Available from: http:\/\/www.infectiologie.com\/UserFiles\/File\/medias\/Recos\/2011-infections-respir-hautes-recommandations.pdf [Accessed on February 10, 2016]."},{"issue":"9","key":"10.1016\/j.medmal.2017.01.007_bib1040","first-page":"CD001095","article-title":"Short-course antibiotics for acute otitis media","author":"Kozyrskyj","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medmal.2017.01.007_bib1045","first-page":"CD006089","article-title":"Antibiotics for clinically diagnosed acute rhinosinusitis in adults","volume":"10","author":"Lemiengre","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00006454-200005000-00013","article-title":"Five vs. ten days of antibiotic therapy for acute otitis media in young children","volume":"19","author":"Cohen","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1055","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0022-3476(98)70103-9","article-title":"A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children","volume":"133","author":"Cohen","year":"1998","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.medmal.2017.01.007_bib1060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.inf.0000180573.21718.36","article-title":"Metaanalysis of short course antibiotic treatment for group a streptococcal tonsillopharyngitis","volume":"24","author":"Casey","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.diagmicrobio.2007.04.010","article-title":"Bacterial eradication rates with shortened courses of 2nd- and 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults","volume":"59","author":"Pichichero","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib1070","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMcp1106638","article-title":"Clinical practice. Acute bacterial sinusitis in children","volume":"367","author":"DeMuri","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/00365549609037947","article-title":"6-day amoxicillin versus 10-day penicillin V for group A beta-haemolytic streptococcal acute tonsillitis in adults: a French multicentre, open-label, randomized study","volume":"28","author":"Peyramond","year":"1996","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2017.01.007_bib1080","first-page":"CD000219","article-title":"Antibiotics for acute otitis media in children","volume":"6","author":"Venekamp","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib1085","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00006454-199608000-00008","article-title":"Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis","volume":"15","author":"Cohen","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.medmal.2017.01.007_bib1090","series-title":"Antibioth\u00e9rapie par voie g\u00e9n\u00e9rale dans les infections respiratoires basses de l\u2019adulte","author":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise","year":"2010"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.200604-535ED","article-title":"A CAP on antibiotic duration","volume":"174","author":"Wunderink","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.286.1.49","article-title":"Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","volume":"286","author":"Schrag","year":"2001","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.279.5.365","article-title":"Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae","volume":"279","author":"Guillemot","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1110","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jac\/dkn201","article-title":"Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis","volume":"62","author":"Falagas","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1115","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1086\/377539","article-title":"High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm","volume":"37","author":"Dunbar","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/377567","article-title":"Short-course treatment of community-acquired pneumonia","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib1125","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0149-2918(05)80214-0","article-title":"A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged>or=65 years with community-acquired pneumonia","volume":"27","author":"Shorr","year":"2005","journal-title":"Clin Ther"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib1130","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.rmed.2006.03.019","article-title":"Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III\/IV community-acquired pneumonia patients","volume":"100","author":"Shorr","year":"2006","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1135","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1378\/chest.128.4.2230","article-title":"Single-dose azithromycin microspheres vs. clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults","volume":"128","author":"Drehobl","year":"2005","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.medmal.2017.01.007_bib1140","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.49.10.4035-4041.2005","article-title":"Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired pneumonia in adults","volume":"49","author":"D\u2019Ignazio","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.medmal.2017.01.007_bib1145","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/S0924-8579(05)80321-8","article-title":"Value of short-course antimicrobial therapy in community-acquired pneumonia","volume":"26","author":"Blasi","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"7554","key":"10.1016\/j.medmal.2017.01.007_bib1150","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.332.7554.1355","article-title":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study","volume":"332","author":"Moussaoui el","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.medmal.2017.01.007_bib1155","first-page":"369","article-title":"Efficacy of a ten-day course of ceftriaxone compared to a shortened five-day course in the treatment of community-acquired pneumonia in hospitalized adults with risk factors","volume":"32","author":"Leophonte","year":"2002","journal-title":"Med Mal Infect"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","article-title":"Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial","volume":"174","author":"Christ-Crain","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.medmal.2017.01.007_bib1165","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs. standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1170","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1440-1843.2011.01978.x","article-title":"Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia","volume":"16","author":"Long","year":"2011","journal-title":"Respirol Carlton Vic"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1469-0691.2009.02709.x","article-title":"Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission \u2013 a randomized trial","volume":"15","author":"Kristoffersen","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.medmal.2017.01.007_bib1180","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11606-013-2400-x","article-title":"Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia","volume":"28","author":"Smith","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1185","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/ebch.1927","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","volume":"8","author":"Schuetz","year":"2013","journal-title":"Evid Based Child Health Cochrane Rev J"},{"issue":"9","key":"10.1016\/j.medmal.2017.01.007_bib1190","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.amjmed.2007.04.023","article-title":"Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis","volume":"120","author":"Li","year":"2007","journal-title":"Am J Med"},{"issue":"13","key":"10.1016\/j.medmal.2017.01.007_bib1195","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2165\/00003495-200868130-00004","article-title":"Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis","volume":"68","author":"Dimopoulos","year":"2008","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.medmal.2017.01.007_bib1200","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/cid\/cis242","article-title":"Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia","volume":"54","author":"Avdic","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/dkt362","article-title":"A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infections","volume":"69","author":"Murray","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.01.007_bib1210","unstructured":"WHO. Pocket book of hospital care for children: Second edition [Internet]. WHO. Available from: http:\/\/www.who.int\/maternal_child_adolescent\/documents\/child_hospital_care\/en\/ [Accessed on January 30, 2016]."},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/INF.0000000000000023","article-title":"Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib1220","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1185\/030079904125003944","article-title":"Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs. clarithromycin: results from two randomized, double-blind, clinical trials","volume":"20","author":"Niederman","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1225","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1185\/030079904125003610","article-title":"Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days","volume":"20","author":"Tellier","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.medmal.2017.01.007_bib1230","doi-asserted-by":"crossref","first-page":"b1374","DOI":"10.1136\/bmj.b1374","article-title":"Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial","volume":"338","author":"Cals","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1235","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1370\/afm.1090","article-title":"Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial","volume":"8","author":"Cals","year":"2010","journal-title":"Ann Fam Med"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/02813430050202541","article-title":"Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice","volume":"18","author":"Diederichsen","year":"2000","journal-title":"Scand J Prim Health Care"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.06-1500","article-title":"Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.medmal.2017.01.007_bib1250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archinternmed.2012.770","article-title":"Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in \u201creal life\u201d: an international, multicenter poststudy survey (ProREAL)","volume":"172","author":"Albrich","year":"2012","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1016\/j.medmal.2017.01.007_bib1255","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/archinte.168.18.2000","article-title":"Procalcitonin-guided antibiotic use vs. a standard approach for acute respiratory tract infections in primary care","volume":"168","author":"Briel","year":"2008","journal-title":"Arch Intern Med"},{"issue":"9409","key":"10.1016\/j.medmal.2017.01.007_bib1260","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","article-title":"Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial","volume":"363","author":"Christ-Crain","year":"2004","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.01.007_bib1270","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1624-0693(03)00051-3","article-title":"R\u00e9actualisation de la douzi\u00e8me conf\u00e9rence de consensus de la Soci\u00e9t\u00e9 de r\u00e9animation de langue fran\u00e7aise (SRLF)\u00a0: infections li\u00e9es aux cath\u00e9ters veineux centraux en r\u00e9animation","volume":"12","author":"Timsit","year":"2003","journal-title":"Reanimation"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib1275","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10096-003-1041-0","article-title":"Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?","volume":"22","author":"Pigrau","year":"2003","journal-title":"Eur J Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/clinids\/14.1.75","article-title":"Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review","volume":"14","author":"Raad","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1285","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/PL00011278","article-title":"Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia","volume":"20","author":"Zeylemaker","year":"2001","journal-title":"Eur J Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/MD.0b013e318030d344","article-title":"Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications","volume":"86","author":"Ghanem","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.medmal.2017.01.007_bib1295","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinte.1995.00430110069007","article-title":"Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters","volume":"155","author":"Malanoski","year":"1995","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1300","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archinte.1989.00390030039007","article-title":"Short-course therapy for catheter-associated Staphylococcus aureus bacteremia","volume":"149","author":"Ehni","year":"1989","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1305","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/clinids\/9.5.891","article-title":"Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia","volume":"9","author":"Mylotte","year":"1987","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0196-6553(87)90069-1","article-title":"Staphylococcus aureus bacteremia caused by infected intravenous catheters","volume":"15","author":"Mylotte","year":"1987","journal-title":"Am J Infect Control"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1315","doi-asserted-by":"crossref","first-page":"558","DOI":"10.7326\/0003-4819-84-5-558","article-title":"Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection","volume":"84","author":"Iannini","year":"1976","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1320","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/AAC.01021-12","article-title":"Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study","volume":"57","author":"Chong","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 4","key":"10.1016\/j.medmal.2017.01.007_bib1325","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0924-8579(09)70567-9","article-title":"Short-course therapy for bloodstream infections in immunocompetent adults","volume":"34","author":"Corey","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1330","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/dkh416","article-title":"Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy","volume":"54","author":"Corona","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.medmal.2017.01.007_bib1335","first-page":"841","article-title":"Short-course monotherapy strategy for treating bacteremia in the critically ill","volume":"72","author":"Corona","year":"2006","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1340","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/dku338","article-title":"Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013","volume":"70","author":"De Santis","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1345","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1186\/cc10545","article-title":"Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis","volume":"15","author":"Havey","year":"2011","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1350","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jac\/dkt424","article-title":"Short versus prolonged courses of antibiotic therapy for children with uncomplicated Gram-negative bacteraemia","volume":"69","author":"Park","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.01.007_bib1355","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13063-015-0688-z","article-title":"Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial","volume":"16","author":"Daneman","year":"2015","journal-title":"Trials"},{"issue":"19","key":"10.1016\/j.medmal.2017.01.007_bib1360","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medmal.2017.01.007_bib1365","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.medmal.2017.01.007_bib1370","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.medmal.2017.01.007_bib1375","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1380","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/338233","article-title":"Enterococcal endocarditis in Sweden, 1995\u20131999: can shorter therapy with aminoglycosides be used?","volume":"34","author":"Olaison","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.medmal.2017.01.007_bib1385","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.112.001170","article-title":"Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome","volume":"127","author":"Dahl","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1390","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/clinids\/21.6.1406","article-title":"Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study","volume":"21","author":"Francioli","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib1395","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-125-12-199612150-00005","article-title":"Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial","volume":"125","author":"Ribera","year":"1996","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.medmal.2017.01.007_bib1400","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-121-11-199412010-00009","article-title":"Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users","volume":"121","author":"DiNubile","year":"1994","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1405","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkl044","article-title":"The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials","volume":"57","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.medmal.2017.01.007_bib1410","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.ijantimicag.2010.11.006","article-title":"Aminoglycoside-containing antibiotic combinations for the treatment of bacterial endocarditis: an evidence-based approach","volume":"36","author":"Leibovici","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1415","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jac\/dku383","volume":"70","author":"Sandoe","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib1420","first-page":"785","article-title":"Infective endocarditis","volume":"369","author":"Hoen","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1425","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/515038","article-title":"Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci","volume":"27","author":"Sexton","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1430","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","article-title":"Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study","volume":"97","author":"Korzeniowski","year":"1982","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1435","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-90-5-789","article-title":"Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers","volume":"90","author":"Abrams","year":"1979","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1440","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1128\/AAC.23.1.36","article-title":"Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin","volume":"23","author":"Coppens","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1445","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7326\/0003-4819-93-6-796","article-title":"Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis","volume":"93","author":"Rajashekaraiah","year":"1980","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.medmal.2017.01.007_bib1450","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1455","first-page":"175","article-title":"[17th Consensus conference. Consensus conference on bacterial meningitis. Short text]","volume":"39","author":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise","year":"2009","journal-title":"Med Mal Infect"},{"issue":"9482","key":"10.1016\/j.medmal.2017.01.007_bib1460","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0140-6736(05)66792-X","article-title":"Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study","volume":"366","author":"Nathan","year":"2005","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib1465","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1445-5994.2004.00601.x","article-title":"Short course intravenous benzylpenicillin treatment of adults with meningococcal disease","volume":"34","author":"Briggs","year":"2004","journal-title":"Intern Med J"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib1470","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/adc.2008.151563","article-title":"Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children","volume":"94","author":"Karageorgopoulos","year":"2009","journal-title":"Arch Dis Child"},{"issue":"9780","key":"10.1016\/j.medmal.2017.01.007_bib1475","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0140-6736(11)60580-1","article-title":"5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study","volume":"377","author":"Molyneux","year":"2011","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1480","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1485","first-page":"117","article-title":"Guidelines for management of intra-abdominal infections","volume":"34","author":"Montravers","year":"2015","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1490","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/sur.2012.077","article-title":"Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections","volume":"15","author":"Riccio","year":"2014","journal-title":"Surg Infect"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1495","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11605-007-0277-x","article-title":"A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs. >or=5 days in community-acquired intraabdominal infection","volume":"12","author":"Basoli","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"21","key":"10.1016\/j.medmal.2017.01.007_bib1500","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","article-title":"Trial of short-course antimicrobial therapy for intraabdominal infection","volume":"372","author":"Sawyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2017.01.007_bib1505","series-title":"26th ECCMID","article-title":"Duration of antibiotic therapy in post-operative peritonitis: the DURAPOP study","author":"Montravers","year":"2016"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1510","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/bjs.7376","article-title":"Use of antibiotics in uncomplicated diverticulitis","volume":"98","author":"de Korte","year":"2011","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1515","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.2013.282025","article-title":"Sigmoid diverticulitis: a systematic review","volume":"311","author":"Morris","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2017.01.007_bib1520","first-page":"CD009092","article-title":"Antibiotics for uncomplicated diverticulitis","volume":"11","author":"Shabanzadeh","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1525","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/bjs.8688","article-title":"Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis","volume":"99","author":"Chabok","year":"2012","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1530","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00330-001-1143-y","article-title":"Colonic diverticulitis: impact of imaging on surgical management \u2013 a prospective study of 542 patients","volume":"12","author":"Ambrosetti","year":"2002","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1535","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/0016-5085(91)90677-D","article-title":"Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients","volume":"100","author":"Runyon","year":"1991","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1540","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club","volume":"32","author":"Rimola","year":"2000","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2017.01.007_bib1545","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis","volume":"56","author":"Fern\u00e1ndez","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1550","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.medmal.2017.01.007_bib1555","unstructured":"Prise en charge des complications des cirrhoses \u2013 Argumentaire [Internet]. Available from: http:\/\/www.has-sante.fr\/portail\/plugins\/ModuleXitiKLEE\/types\/FileDocument\/doXiti.jsp?id=c_670742 [Accessed on January 16, 2016]."},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1560","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.2014.7586","article-title":"Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial","volume":"312","author":"Regimbeau","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib1565","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1445-2197.1990.tb07422.x","article-title":"Systemic antibiotic regimens for acute cholecystitis treated by early cholecystectomy","volume":"60","author":"Lau","year":"1990","journal-title":"Aust N Z J Surg"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1570","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00534-006-1160-y","article-title":"Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines","volume":"14","author":"Yoshida","year":"2007","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib1575","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1007\/s00268-012-1572-6","article-title":"Role of antibiotic therapy in mild acute calculus cholecystitis: a prospective randomized controlled trial","volume":"36","author":"Mazeh","year":"2012","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib1580","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00535-011-0451-5","article-title":"Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage","volume":"46","author":"Kogure","year":"2011","journal-title":"J Gastroenterol"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1585","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1067\/mge.2002.122334","article-title":"Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract","volume":"55","author":"van Lent","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.medmal.2017.01.007_bib1590","unstructured":"hcspr20100129_gastro.pdf [Internet]. Available from: http:\/\/www.hcsp.fr\/explore.cgi\/hcspr20100129_gastro.pdf [Accessed on January 16, 2016]."},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1595","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/AAC.36.1.87","article-title":"Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study","volume":"36","author":"DuPont","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1600","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/510589","article-title":"Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen","volume":"44","author":"Tribble","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.medmal.2017.01.007_bib1605","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7326\/0003-4819-117-9-727","article-title":"Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial","volume":"117","author":"Bennish","year":"1992","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib1610","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1469-0691.2011.03552.x","article-title":"Treatment of typhoid fever in the 21st century: promises and shortcomings","volume":"17","author":"Butler","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib1615","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","article-title":"A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever","volume":"44","author":"Chinh","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib1620","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/382359","article-title":"Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents","volume":"38","author":"Frenck","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1625","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/44.2.243","article-title":"Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India","volume":"44","author":"Butler","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.medmal.2017.01.007_bib1630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1635","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00384-010-0899-4","article-title":"Prospective randomized trial comparing short-term antibiotic therapy versus standard therapy for acute uncomplicated sigmoid diverticulitis","volume":"25","author":"Schug-Pass","year":"2010","journal-title":"Int J Colorectal Dis"},{"issue":"10 Online","key":"10.1016\/j.medmal.2017.01.007_bib1640","first-page":"e278","article-title":"Outpatient treatment of patients with uncomplicated acute diverticulitis","volume":"12","author":"Alonso","year":"2010","journal-title":"Colorectal Dis"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1645","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00365520600780650","article-title":"Conservative treatment of acute colonic diverticulitis: are antibiotics always mandatory?","volume":"42","author":"Hjern","year":"2007","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib1650","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1128\/AAC.33.7.1101","article-title":"Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults","volume":"33","author":"Gotuzzo","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1655","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.lpm.2009.06.007","article-title":"[Diagnosis and treatment of community-acquired urinary tract infections in adults: what has changed. Comments on the 2008 guidelines of the French Health Products Safety Agency (AFSSAPS)]","volume":"39","author":"Caron","year":"2010","journal-title":"Presse Med"},{"key":"10.1016\/j.medmal.2017.01.007_bib1660","unstructured":"Recommandations bonne pratique pour la prise en charge et la prevention des infections urinaires associ\u00e9es aux soins de l\u2019adulte 2015 [Internet]. Available from: http:\/\/sf2h.net\/actus\/recommandations_bonne-pratique-pour-la-prise-en-charge-et-la-prevention-des-infections-urinaires-associees-aux-soins-de-l-adulte-2015.pdf [Accessed on January 16, 2016]."},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib1665","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00365540110080728","article-title":"Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women","volume":"34","author":"Nicolle","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1670","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/AAC.47.3.897-900.2003","article-title":"Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women","volume":"47","author":"Kavatha","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"20","key":"10.1016\/j.medmal.2017.01.007_bib1675","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/archinte.167.20.2207","article-title":"Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women","volume":"167","author":"Gupta","year":"2007","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.medmal.2017.01.007_bib1680","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-114-9-713","article-title":"How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study","volume":"114","author":"Harding","year":"1991","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1685","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0022-5347(17)43138-7","article-title":"Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder","volume":"138","author":"Mohler","year":"1987","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1690","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/423000","article-title":"A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury","volume":"39","author":"Dow","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1695","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1700","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2007.09.002","article-title":"A double-blind, randomized comparison of levofloxacin 750mg once-daily for five days with ciprofloxacin 400\/500mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis","volume":"71","author":"Peterson","year":"2008","journal-title":"Urology"},{"issue":"2 Pt 1","key":"10.1016\/j.medmal.2017.01.007_bib1705","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.ju.0000106191.11936.64","article-title":"Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis","volume":"171","author":"Talan","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1710","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/0036554021000026988","article-title":"Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up","volume":"35","author":"Ulleryd","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"10.1016\/j.medmal.2017.01.007_bib1715","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/jac\/dkt177","article-title":"Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection \u2013 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials","volume":"68","author":"Eliakim-Raz","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2017.01.007_bib1720","series-title":"Mise au point\u00a0: traitement antibiotique probabliste des ur\u00e9trites et cervicites non compliqu\u00e9es, afssaps","year":"2008"},{"key":"10.1016\/j.medmal.2017.01.007_bib1725","series-title":"Ur\u00e9trites et cervicites non compliqu\u00e9es\u00a0: strat\u00e9gie diagnostique et th\u00e9rapeutique de prise en charge","year":"2016"},{"issue":"Suppl. 8","key":"10.1016\/j.medmal.2017.01.007_bib1730","doi-asserted-by":"crossref","first-page":"S759","DOI":"10.1093\/cid\/civ771","article-title":"Centers for disease control and prevention sexually transmitted diseases treatment guidelines","volume":"61","author":"Workowski","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.01.007_bib1735","unstructured":"SUN\/1ann\/8p \u2013 apercu [Internet]. Available from: http:\/\/www.cngof.fr\/pratiques-cliniques\/recommandations-pour-la-pratique-clinique\/apercu?path=RPC%2BCOLLEGE%252FRPC_infections_2012.pdf&i=459 [Accessed on March 6, 2016]."},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0956462413498714","article-title":"International Union against sexually transmitted infections. 2012 European guideline for the management of pelvic inflammatory disease","volume":"25","author":"Ross","year":"2014","journal-title":"Int J STD AIDS"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1745","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007611-199306000-00002","article-title":"Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease","volume":"86","author":"Martens","year":"1993","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1750","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0028-2243(93)90180-K","article-title":"A comparison of pefloxacin\/metronidazole and doxycycline\/metronidazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease","volume":"50","author":"Witte","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1755","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/clinids\/24.2.170","article-title":"Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients","volume":"24","author":"Arredondo","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.medmal.2017.01.007_bib1760","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1093\/clinids\/24.Supplement_2.S222","article-title":"A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women","volume":"24","author":"Hemsell","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1765","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/147323000303100108","article-title":"Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease","volume":"31","author":"Bevan","year":"2003","journal-title":"J Int Med Res"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1770","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/sti.2005.019109","article-title":"Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial","volume":"82","author":"Ross","year":"2006","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1775","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000268801.90261.27","article-title":"Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial","volume":"110","author":"Savaris","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.medmal.2017.01.007_bib1780","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1258\/ijsa.2008.008495","article-title":"A randomized double-blind comparison of moxifloxacin and doxycycline\/metronidazole\/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease","volume":"20","author":"Heystek","year":"2009","journal-title":"Int J STD AIDS"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib1785","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1471-0528.2010.02687.x","article-title":"Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study","volume":"117","author":"Judlin","year":"2010","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1790","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejogrb.2013.08.012","article-title":"Single daily dose of moxifloxacin versus ofloxacin plus metronidazole as a new treatment approach to uncomplicated pelvic inflammatory disease: a multicentre prospective randomized trial","volume":"171","author":"A\u015ficio\u011flu","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl. 8","key":"10.1016\/j.medmal.2017.01.007_bib1795","doi-asserted-by":"crossref","first-page":"S802","DOI":"10.1093\/cid\/civ785","article-title":"Efficacy of antimicrobial therapy for mycoplasma genitalium Infections","volume":"61","author":"Manhart","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1800","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.05.021","article-title":"Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?","volume":"198","author":"Trautmann","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"16","key":"10.1016\/j.medmal.2017.01.007_bib1805","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1810","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.medmal.2009.12.009","article-title":"Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis)","volume":"40","author":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise (SPILF)","year":"2010","journal-title":"Med Mal Infect"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cis966","article-title":"Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.medmal.2017.01.007_bib1820","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1302\/0301-620X.95B11.33135","article-title":"Proceedings of the International Consensus on Periprosthetic Joint Infection","volume":"95B","author":"Parvizi","year":"2013","journal-title":"Bone Joint J"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2017.01.007_bib1825","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/jac\/dku253","article-title":"Clinical guidelines in the management of prosthetic joint infection","volume":"69","author":"Minassian","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"19","key":"10.1016\/j.medmal.2017.01.007_bib1830","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1835","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cis746","article-title":"A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention","volume":"56","author":"Lora-Tamayo","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1840","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jinf.2010.05.005","article-title":"Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty","volume":"61","author":"Bernard","year":"2010","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.medmal.2017.01.007_bib1845","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-0691.2005.01230.x","article-title":"Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections","volume":"11","author":"Berdal","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1850","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/17453674.2012.678801","article-title":"Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years","volume":"83","author":"Westberg","year":"2012","journal-title":"Acta Orthop"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1855","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2106\/JBJS.L.01451","article-title":"One-stage exchange arthroplasty for chronic periprosthetic hip infection: results of a large prospective cohort study","volume":"96","author":"Zeller","year":"2014","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1860","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10096-009-0842-1","article-title":"Six weeks antibiotic therapy for all bone infections: results of a cohort study","volume":"29","author":"Farhad","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.medmal.2017.01.007_bib1865","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1469-0691.2011.03693.x","article-title":"Short-course antibiotics for prosthetic joint infections treated with prosthesis retention","volume":"18","author":"Puhto","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1870","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1302\/0301-620X.90B2.19855","article-title":"The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement","volume":"90","author":"Stockley","year":"2008","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.medmal.2017.01.007_bib1875","series-title":"ICAAC","article-title":"Treatment associated with 6 weeks antibiotic is effective","author":"Chaussade","year":"2013"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1880","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/dki016","article-title":"Linezolid in the treatment of Gram-positive prosthetic joint infections","volume":"55","author":"Bassetti","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib1885","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/jac\/dkp177","article-title":"Two-stage revision of infected hip arthroplasty using an antibiotic-loaded spacer: retrospective comparison between short-term and prolonged antibiotic therapy","volume":"64","author":"Hsieh","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1890","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00402-008-0683-x","article-title":"Two-stage revision of infected hip arthroplasty using a shortened post-operative course of antibiotics","volume":"129","author":"McKenna","year":"2009","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1895","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1302\/0301-620X.91B1.20930","article-title":"Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection?","volume":"91","author":"Whittaker","year":"2009","journal-title":"J Bone Joint Surg Br"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1900","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2106\/00004623-200706000-00010","article-title":"Two-stage reimplantation for periprosthetic knee infection involving resistant organisms","volume":"89","author":"Mittal","year":"2007","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1905","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/clinids\/24.5.914","article-title":"Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention","volume":"24","author":"Brandt","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1910","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1469-0691.2006.01378.x","article-title":"Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre","volume":"12","author":"Laffer","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1915","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1469-0691.2010.03244.x","article-title":"Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement","volume":"17","author":"Vilchez","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib1925","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2017.01.007_bib1930","first-page":"CD004439","article-title":"Antibiotics for treating chronic osteomyelitis in adults","volume":"9","author":"Conterno","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib1935","first-page":"735","article-title":"Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study","volume":"38","author":"Tone","year":"2015","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1940","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijid.2004.09.009","article-title":"Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?","volume":"9","author":"Lazzarini","year":"2005","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.medmal.2017.01.007_bib1945","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0399-077X(05)80112-X","article-title":"Traitement des infections ost\u00e9o-articulaires bact\u00e9riennes en dehors des infections \u00e0 mycobact\u00e9ries","volume":"21","author":"Choutet","year":"1991","journal-title":"Med Mal Infect"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib1950","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/rheumatology\/kel163a","article-title":"BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults","volume":"45","author":"Coakley","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.medmal.2017.01.007_bib1955","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.rhum.2005.09.009","article-title":"Antibioth\u00e9rapie des infections ost\u00e9oarticulaires \u00e0 pyog\u00e8nes chez l\u2019adulte\u00a0: principes et modalit\u00e9s","volume":"73","author":"Zeller","year":"2006","journal-title":"Rev Rhum"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib1960","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.semarthrit.2015.01.009","article-title":"Pyogenic arthritis of native joints in non-intravenous drug users: a detailed analysis of 268 cases attended in a tertiary hospital over a 22-year period","volume":"45","author":"Nolla","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib1965","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/j.ijid.2011.12.019","article-title":"Short parenteral antibiotic treatment for adult septic arthritis after successful drainage","volume":"17","author":"U\u00e7kay","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib1975","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.semarthrit.2006.09.004","article-title":"Optimal duration of antibiotic therapy in vertebral osteomyelitis","volume":"36","author":"Roblot","year":"2007","journal-title":"Semin Arthritis Rheum"},{"issue":"9971","key":"10.1016\/j.medmal.2017.01.007_bib1980","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(14)61233-2","article-title":"Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial","volume":"385","author":"Bernard","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib1985","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.medmal.2017.01.007_bib1990","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medmal.2017.01.007_bib1995","series-title":"Acute bacterial skin and skin structure infections: developing drugs for treatment [ucm071185.pdf] [Internet]","year":"2016"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib2000","first-page":"655","article-title":"[Consensus conference on erysipelas and necrotizing fasciitis, Tours, January 26, 2000]","volume":"21","author":"Veyssier-Belot","year":"2000","journal-title":"Rev Med Interne"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib2005","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib2010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/00365549709011834","article-title":"Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study","volume":"29","author":"Bergkvist","year":"1997","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib2015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.1992.tb08048.x","article-title":"Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study","volume":"127","author":"Bernard","year":"1992","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib2020","first-page":"177","article-title":"Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy","volume":"75","author":"Dall","year":"2005","journal-title":"Cutis"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib2025","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/cid\/cit122","article-title":"Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial","volume":"56","author":"Pallin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib2030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/dku397","article-title":"Oral versus parenteral antimicrobials for the treatment of cellulitis: a randomized non-inferiority trial","volume":"70","author":"Aboltins","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.medmal.2017.01.007_bib2035","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1128\/AAC.49.11.4658-4666.2005","article-title":"Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam","volume":"49","author":"Breedt","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib2040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jmii.2010.04.002","article-title":"Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan","volume":"44","author":"Chuang","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib2045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1403789","article-title":"Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections","volume":"372","author":"Miller","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib2050","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1473-3099(14)70737-6","article-title":"Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial","volume":"14","author":"Moran","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib2055","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2013.241","article-title":"Tedizolid phosphate vs. linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.medmal.2017.01.007_bib2060","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","article-title":"Once-weekly dalbavancin versus daily conventional therapy for skin infection","volume":"370","author":"Boucher","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib2065","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib2070","first-page":"CD001738","article-title":"Antibiotic prophylaxis for mammalian bites","author":"Medeiros","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib2075","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib2080","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amjsurg.2009.08.045","article-title":"Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus","volume":"199","author":"Itani","year":"2010","journal-title":"Am J Surg"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib2085","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","article-title":"Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections","volume":"44","author":"Stevens","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"23","key":"10.1016\/j.medmal.2017.01.007_bib2090","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1310422","article-title":"Single-dose oritavancin in the treatment of acute bacterial skin infections","volume":"370","author":"Corey","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.medmal.2017.01.007_bib2095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1445-2197.2009.05018.x","article-title":"Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis)","volume":"79","author":"Dodds","year":"2009","journal-title":"ANZ J Surg"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib2100","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.05738-11","article-title":"CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections","volume":"56","author":"Friedland","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.medmal.2017.01.007_bib2105","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/497271","article-title":"Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections","volume":"41","author":"Jauregui","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib2110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijantimicag.2011.08.007","article-title":"Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections","volume":"39","author":"Quist","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.medmal.2017.01.007_bib2115","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1086\/587896","article-title":"Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms","volume":"46","author":"Stryjewski","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib2120","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib2125","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.medmal.2017.01.007_bib2130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-9343(79)90390-5","article-title":"Duration of empiric antibiotic therapy in granulocytopenic patients with cancer","volume":"67","author":"Pizzo","year":"1979","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib2135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/514500","article-title":"Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study","volume":"25","author":"Santolaya","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.medmal.2017.01.007_bib2140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00043426-200009000-00004","article-title":"Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia","volume":"22","author":"Klaassen","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"10.1016\/j.medmal.2017.01.007_bib2145","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/00365540410017590","article-title":"A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies","volume":"36","author":"Cherif","year":"2004","journal-title":"Scand J Infect Dis"},{"issue":"16","key":"10.1016\/j.medmal.2017.01.007_bib2150","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1016\/j.ejca.2009.06.025","article-title":"Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study","volume":"45","author":"Slobbe","year":"2009","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib2155","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9343(84)90664-8","article-title":"Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?","volume":"76","author":"Joshi","year":"1984","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.medmal.2017.01.007_bib2160","doi-asserted-by":"crossref","first-page":"O453","DOI":"10.1111\/1469-0691.12445","article-title":"Discontinuation of empirical antibiotic therapy in neutropenic acute myeloid leukaemia patients with fever of unknown origin: is it ethical?","volume":"20","author":"Micol","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.medmal.2017.01.007_bib2165","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.cmi.2014.10.014","article-title":"Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical","volume":"21","author":"Orasch","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.medmal.2017.01.007_bib2170","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3324\/haematol.2013.091330","article-title":"Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib2175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2431-5-10","article-title":"Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia","volume":"5","author":"Hodgson-Viden","year":"2005","journal-title":"BMC Pediatr"},{"issue":"6","key":"10.1016\/j.medmal.2017.01.007_bib2180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00000441-199112000-00005","article-title":"Short courses of antibiotics in selected febrile neutropenic patients","volume":"302","author":"Kaplan","year":"1991","journal-title":"Am J Med Sci"},{"issue":"5 Pt 1","key":"10.1016\/j.medmal.2017.01.007_bib2185","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3476(05)81358-7","article-title":"Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition","volume":"124","author":"Jones","year":"1994","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.medmal.2017.01.007_bib2190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s15010-002-2094-1","article-title":"Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer","volume":"30","author":"Lehrnbecher","year":"2002","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.medmal.2017.01.007_bib2195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00043426-199511000-00008","article-title":"Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia. A preliminary prospective trial","volume":"17","author":"Cohen","year":"1995","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17300446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17300446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:15:39Z","timestamp":1759972539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X17300446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":238,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0399077X17300446"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2017.01.007","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proposal for shorter antibiotic therapies","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2017.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}